文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

男性体内的睾酮与胰岛素抵抗:复杂双向关系的证据

TESTOSTERONE AND INSULIN RESISTANCE IN MEN: EVIDENCE FOR A COMPLEX BI-DIRECTIONAL RELATIONSHIP.

作者信息

Hayes Frances J

机构信息

Boston, MA.

出版信息

Trans Am Clin Climatol Assoc. 2025;135:297-305.


DOI:
PMID:40771640
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12323448/
Abstract

Given that low testosterone levels predict type 2 diabetes mellitus (T2DM) in men, we sought to dissect the relationship between testosterone and insulin sensitivity in men. We showed a positive correlation between serum testosterone levels and insulin sensitivity in men across the full spectrum of glucose tolerance. Men with hypogonadal testosterone levels were twice as insulin resistant as eugonadal controls. By dissecting the hypothalamic-pituitary-gonadal axis, we demonstrated that the cause of low testosterone was a decrease in testicular responsiveness to luteinizing hormone (LH). Using functional and genetic studies, we provided evidence that hypogonadism may induce insulin resistance by causing mitochondrial dysfunction. We also showed that weight loss can increase testosterone levels and reverse hypogonadism in over 50% of obese men with impaired glucose tolerance. We concluded that the relationship between testosterone and insulin resistance in men is bidirectional. Our data emphasized the importance of lifestyle modification as a key therapeutic step in the management of the hypogonadal male.

摘要

鉴于低睾酮水平可预测男性2型糖尿病(T2DM),我们试图剖析男性体内睾酮与胰岛素敏感性之间的关系。我们发现,在糖耐量的整个范围内,男性血清睾酮水平与胰岛素敏感性呈正相关。性腺功能减退的男性的胰岛素抵抗是性腺功能正常的对照组的两倍。通过剖析下丘脑-垂体-性腺轴,我们证明低睾酮的原因是睾丸对促黄体生成素(LH)的反应性降低。通过功能和基因研究,我们提供了证据表明性腺功能减退可能通过导致线粒体功能障碍而诱发胰岛素抵抗。我们还表明,体重减轻可使超过50%的糖耐量受损的肥胖男性的睾酮水平升高并逆转性腺功能减退。我们得出结论,男性体内睾酮与胰岛素抵抗之间的关系是双向的。我们的数据强调了生活方式改变作为性腺功能减退男性管理中关键治疗步骤的重要性。

相似文献

[1]
TESTOSTERONE AND INSULIN RESISTANCE IN MEN: EVIDENCE FOR A COMPLEX BI-DIRECTIONAL RELATIONSHIP.

Trans Am Clin Climatol Assoc. 2025

[2]
Metabolic effects of testosterone replacement therapy on hypogonadal men with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.

Asian J Androl. 2014

[3]
Short-term impact of tirzepatide on metabolic hypogonadism and body composition in patients with obesity: a controlled pilot study.

Reprod Biol Endocrinol. 2025-7-2

[4]
Testosterone therapy in diabetes and pre-diabetes.

Andrology. 2023-2

[5]
Hybrid closed-loop systems for managing blood glucose levels in type 1 diabetes: a systematic review and economic modelling.

Health Technol Assess. 2024-12

[6]
Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline.

Eur J Endocrinol. 2025-6-30

[7]
Regulatory Mechanism of Ghrelin on Testosterone Secretion in Type 1 Diabetic Rats.

Reprod Fertil. 2025-7-2

[8]
Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.

Cochrane Database Syst Rev. 2016-10-17

[9]
Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline.

J Clin Endocrinol Metab. 2025-7-13

[10]
Effects of testosterone therapy in adult males with hypogonadism and T2DM: A meta-analysis and systematic review.

Diabetes Metab Syndr. 2022-8

本文引用的文献

[1]
Testosterone in prevention and treatment of type 2 diabetes in men: Focus on recent randomized controlled trials.

Ann N Y Acad Sci. 2024-8

[2]
Cardiovascular Safety of Testosterone-Replacement Therapy.

N Engl J Med. 2023-7-13

[3]
Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial.

Lancet Diabetes Endocrinol. 2021-1

[4]
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.

J Clin Endocrinol Metab. 2018-5-1

[5]
A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management.

J Clin Endocrinol Metab. 2017-3-1

[6]
Association Between Direct-to-Consumer Advertising and Testosterone Testing and Initiation in the United States, 2009-2013.

JAMA. 2017-3-21

[7]
Effects of Testosterone Treatment in Older Men.

N Engl J Med. 2016-2-18

[8]
Effects of Testosterone Administration for 3 Years on Subclinical Atherosclerosis Progression in Older Men With Low or Low-Normal Testosterone Levels: A Randomized Clinical Trial.

JAMA. 2015-8-11

[9]
Testosterone lab testing and initiation in the United Kingdom and the United States, 2000 to 2011.

J Clin Endocrinol Metab. 2014-1-1

[10]
Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels.

JAMA. 2013-11-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索